[go: up one dir, main page]

EG20539A - Process for preparing of dihydraphyridines and their use as pharmaceutical compositions in lowering blood pressure - Google Patents

Process for preparing of dihydraphyridines and their use as pharmaceutical compositions in lowering blood pressure

Info

Publication number
EG20539A
EG20539A EG68994A EG68994A EG20539A EG 20539 A EG20539 A EG 20539A EG 68994 A EG68994 A EG 68994A EG 68994 A EG68994 A EG 68994A EG 20539 A EG20539 A EG 20539A
Authority
EG
Egypt
Prior art keywords
hydrogen
pct
blood pressure
chloro
methyl
Prior art date
Application number
EG68994A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of EG20539A publication Critical patent/EG20539A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
EG68994A 1993-11-05 1994-11-02 Process for preparing of dihydraphyridines and their use as pharmaceutical compositions in lowering blood pressure EG20539A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303657A SE9303657D0 (sv) 1993-11-05 1993-11-05 Short-acting dihydropyridines

Publications (1)

Publication Number Publication Date
EG20539A true EG20539A (en) 1999-07-31

Family

ID=20391655

Family Applications (1)

Application Number Title Priority Date Filing Date
EG68994A EG20539A (en) 1993-11-05 1994-11-02 Process for preparing of dihydraphyridines and their use as pharmaceutical compositions in lowering blood pressure

Country Status (35)

Country Link
US (1) US5856346A (fr)
EP (1) EP0726894B1 (fr)
JP (1) JP3712209B2 (fr)
KR (1) KR100331663B1 (fr)
CN (1) CN1049428C (fr)
AT (1) ATE194330T1 (fr)
AU (1) AU685532B2 (fr)
BR (1) BR9407946A (fr)
CA (1) CA2174969C (fr)
CZ (1) CZ285691B6 (fr)
DE (1) DE69425152T2 (fr)
DK (1) DK0726894T3 (fr)
EE (1) EE03230B1 (fr)
EG (1) EG20539A (fr)
ES (1) ES2150544T3 (fr)
FI (1) FI110429B (fr)
FR (1) FR12C0053I2 (fr)
GR (1) GR3034469T3 (fr)
HU (1) HU215591B (fr)
IL (1) IL111127A (fr)
IS (1) IS1674B (fr)
LU (1) LU92209I2 (fr)
MY (1) MY111770A (fr)
NO (1) NO305656B1 (fr)
NZ (1) NZ275915A (fr)
PL (1) PL185099B1 (fr)
PT (1) PT726894E (fr)
RU (1) RU2139278C1 (fr)
SA (1) SA94150250B1 (fr)
SE (1) SE9303657D0 (fr)
SK (1) SK281467B6 (fr)
TW (1) TW279859B (fr)
UA (1) UA45959C2 (fr)
WO (1) WO1995012578A1 (fr)
ZA (1) ZA947570B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9804002D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New manufacturing process
EP1455804A4 (fr) * 2001-12-21 2005-01-05 Alcon Inc Utilisation de nanoparticules en tant qu'excipients pour biocides dans des compositions ophtalmiques
FR2922439B1 (fr) * 2007-10-18 2010-12-10 Hill Rom Ind Sa Procede de gonflage alterne d'un dispositif de support a cellules gonflables et dispositif pour sa mise en oeuvre
US20100113534A1 (en) 2008-08-01 2010-05-06 Rajeshwar Motheram Pharmaceutical Compositions And Methods For Producing Low Impurity Concentrations Of The Same
KR20120100945A (ko) * 2009-09-30 2012-09-12 마이크로도스 테라퓨특스, 인코포레이티드 레이노 증후군의 치료를 위한 방법들 및 조성물들
CN101780036B (zh) * 2010-03-30 2011-11-16 武汉武药科技有限公司 丁酸氯维地平脂微球注射液及其制备方法
CA2701087A1 (fr) * 2010-04-12 2011-10-12 Alphora Research Inc. Preparation de butyrate de clevidipine
US8455655B2 (en) 2010-05-07 2013-06-04 Laboratorios Lesvi, S.L. Preparation of dihydropyridines
ES2571043T3 (es) 2010-05-07 2016-05-23 Lesvi Laboratorios Sl Preparación de dihidropiridinas
EA022849B1 (ru) 2010-10-12 2016-03-31 Дзе Медсинз Компани Эмульсионные композиции клевидипина, содержащие противомикробные агенты
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
EP2694063A1 (fr) * 2011-04-01 2014-02-12 The Medicines Company Utilisation des dihydropyridines (clévidipine) à courte durée d'action pour réduire des lésions consécutives à un accident vasculaire cérébral
CA2846387C (fr) 2011-08-26 2016-02-09 Wockhardt Limited Procedes de traitement de troubles cardiovasculaires
CN103420899B (zh) * 2012-05-25 2016-01-27 四川科伦药物研究有限公司 一种丁酸氯维地平的纯化方法
MX359768B (es) 2012-10-26 2018-10-10 Chiesi Farm Spa Métodos para controlar la presión arterial y para reducir la disnea durante una insuficiencia cardiaca.
CN103073485B (zh) * 2013-01-17 2015-09-02 北京嘉林药业股份有限公司 一种丁酸氯维地平的制备方法
CN103086956B (zh) * 2013-01-17 2015-11-04 北京嘉林药业股份有限公司 一种丁酸氯维地平中间体的纯化方法
KR102380701B1 (ko) 2014-05-19 2022-03-31 치에시 파마슈티시 에스.피.아. 클레비디핀 나노입자 및 그의 제약적 조성물
CN105367487A (zh) * 2014-08-23 2016-03-02 南京海纳医药科技有限公司 一种丁酸氯维地平重要中间体新的合成方法
CN104370802A (zh) * 2014-09-24 2015-02-25 北京蓝丹医药科技有限公司 氯维地平衍生物及其制备方法
BR112017024773A2 (pt) 2015-05-20 2018-11-06 Merial, Inc. compostos depsipeptídeos anti-helmínticos
WO2017116702A1 (fr) 2015-12-28 2017-07-06 Merial, Inc. Composés depsipeptidiques anthelminthiques
BR112019009977A2 (pt) 2016-11-16 2019-08-27 Boehringer Ingelheim Animal Health Usa Inc compostos depsipeptídicos anti-helmínticos
RU2755349C1 (ru) * 2021-02-16 2021-09-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Применение бензил 6-({ 2-[(3,4-диметилфенил)амино]-2-оксоэтил} тио)-2-метил-4-(4-хлорфенил)-5-циано-1,4-дигидропиридин-3-карбоксилата в качестве гепатопротекторного средства

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4154839A (en) * 1975-11-05 1979-05-15 Bayer Aktiengesellschaft 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
KR940003492B1 (ko) * 1988-10-27 1994-04-23 주식회사 유한양행 1,4-디하이드로피리딘유도체 및 그의 제조방법
US5134139A (en) * 1989-08-31 1992-07-28 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and preparation thereof
JPH0641075A (ja) * 1990-09-01 1994-02-15 Kazuo Achinami 新規な1,4−ジヒドロピリジン化合物及びその製造方法

Also Published As

Publication number Publication date
KR100331663B1 (ko) 2002-09-26
JPH09504542A (ja) 1997-05-06
GR3034469T3 (en) 2000-12-29
FR12C0053I2 (fr) 2013-08-16
IS1674B (is) 1997-12-31
US5856346A (en) 1999-01-05
AU685532B2 (en) 1998-01-22
DE69425152D1 (de) 2000-08-10
UA45959C2 (uk) 2002-05-15
FI110429B (fi) 2003-01-31
NO305656B1 (no) 1999-07-05
CN1049428C (zh) 2000-02-16
MY111770A (en) 2000-12-30
CN1137269A (zh) 1996-12-04
SE9303657D0 (sv) 1993-11-05
SK281467B6 (sk) 2001-04-09
ZA947570B (en) 1995-05-29
EP0726894A1 (fr) 1996-08-21
PL314128A1 (en) 1996-08-19
RU2139278C1 (ru) 1999-10-10
AU8119694A (en) 1995-05-23
PL185099B1 (pl) 2003-02-28
HU215591B (hu) 1999-01-28
NZ275915A (en) 1997-04-24
NO961776D0 (no) 1996-05-02
ES2150544T3 (es) 2000-12-01
EE03230B1 (et) 1999-10-15
NO961776L (no) 1996-05-02
FI961914L (fi) 1996-05-06
HK1013292A1 (en) 1999-08-20
IS4218A (is) 1995-05-06
CZ127396A3 (en) 1996-09-11
JP3712209B2 (ja) 2005-11-02
TW279859B (fr) 1996-07-01
FI961914A0 (fi) 1996-05-06
LU92209I2 (fr) 2013-08-23
DK0726894T3 (da) 2000-10-23
BR9407946A (pt) 1996-11-26
CA2174969A1 (fr) 1995-05-11
CZ285691B6 (cs) 1999-10-13
EP0726894B1 (fr) 2000-07-05
WO1995012578A1 (fr) 1995-05-11
CA2174969C (fr) 2005-05-17
PT726894E (pt) 2000-10-31
DE69425152T2 (de) 2001-03-22
SK55996A3 (en) 1996-12-04
ATE194330T1 (de) 2000-07-15
HU9601187D0 (en) 1996-07-29
FR12C0053I1 (fr) 2012-02-11
HUT75316A (en) 1997-05-28
IL111127A0 (en) 1994-12-29
SA94150250B1 (ar) 2006-03-01
IL111127A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
EG20539A (en) Process for preparing of dihydraphyridines and their use as pharmaceutical compositions in lowering blood pressure
ZA931073B (en) Hypolipidaemic compounds
NZ238206A (en) The stereoselective preparation of phenylisoserine derivatives and the use of such derivatives in preparing baccatin-iii and 10-deacetylbaccatin-iii derivatives
IE892795L (en) Ó,Ó-Disubstituted N-cycloalkylalkylbenzylamines, process for¹their preparation, their use as a medicament and their¹synthesis intermediates
IL108969A0 (en) Substituted (arylalkoxybenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
CA2042113A1 (fr) Spiro-isoquinoleinepyrrolidine et leurs analogues, utiles comme agents inhibiteurs de l'aldose-reductase
GB9114947D0 (en) Process for preparing sertraline
IL113002A0 (en) 4 - methylene - 2H - chromen - 3(4H)- one derivatives their preparation and use
HUT64309A (en) Process for production pharmaceutical preparations having benzazepine compounds as effective substance and the new effective substance
ZA941964B (en) Substituted (arylalkylaminobezyl) aminopropionamide derivatives and process for their preparation
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
AU5111393A (en) Benzopyranones, method of preparing them and their use
HU886767D0 (en) Process for the preparation of new 20,21-dinor-eburnamenine derivatives, new intermediates thereof, as well as pharmaceutical compositions containing said compounds as active ingredients
ES8207519A1 (es) Procedimiento para la obtencion de derivados del imidazol.
GR3000773T3 (en) 2,2;6,6-diethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactones, process for their preparation and pharmaceutical compositions containing them
ATE96803T1 (de) Indolo(3,2,1-de>(1,4>-oxazino(2,3,4ij>(1,5>naphthyridinderivate, verfahren zu ihrer herstellung und zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.